When to Start GLP-1 Receptor Agonist (Semaglutide)
You can start semaglutide as soon as your provider reviews the pending lab results and confirms no contraindications—there is no mandatory waiting period beyond ensuring basic safety screening is complete. 1
Pre-Initiation Requirements
Before starting semaglutide, your provider needs to verify:
- No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) – these are absolute contraindications 1
- No active or suspected pancreatitis – semaglutide has not been studied in patients with pancreatitis history 1
- Basic metabolic labs – though semaglutide requires no dose adjustment for renal or hepatic impairment, baseline assessment helps establish your starting point 1
The lab work your provider ordered is likely checking A1C, kidney function, and liver enzymes—standard pre-treatment assessment. Once these return and show no contraindications, you can proceed immediately.
Starting Protocol
Semaglutide follows a mandatory dose escalation schedule 1:
- Week 0-4: Start at 0.25 mg once weekly (this is NOT a therapeutic dose—it's only for tolerability)
- Week 4+: Increase to 0.5 mg once weekly (first therapeutic dose)
- Week 8+ (if needed): May increase to 1 mg once weekly for additional glycemic control
This gradual titration minimizes gastrointestinal side effects (nausea, vomiting, diarrhea), which are the most common adverse events 2, 3.
Administration Details
- Inject subcutaneously in abdomen, thigh, or upper arm 1
- Once weekly, same day each week, any time of day, with or without meals 1
- Rotate injection sites each week within the same body region 1
- If you miss a dose, take it within 5 days; if >5 days have passed, skip and resume regular schedule 1
Clinical Context from Guidelines
Current diabetes guidelines strongly favor GLP-1 receptor agonists like semaglutide when A1C is above goal on metformin, particularly if you have cardiovascular disease or need weight loss 4, 5. GLP-1 RAs should be considered before adding prandial insulin to minimize hypoglycemia risk and weight gain 5.
Your Appointment Timeline
Your upcoming appointments are appropriately structured:
- Current visit: Provider reviews labs
- Next appointment: Likely prescription and initiation if labs are clear
- Follow-up with provider: Monitor tolerance during dose escalation phase
There is no medical reason to delay starting semaglutide beyond confirming the absence of contraindications. The medication has a ~1 week half-life, so it takes 4-5 weeks to reach steady state—starting sooner means reaching therapeutic benefit sooner 1.
Common Pitfall to Avoid
Do not expect immediate glycemic improvement during the first 4 weeks at 0.25 mg—this dose is sub-therapeutic and exists only to reduce GI side effects. Meaningful A1C reduction occurs at 0.5 mg and above 1, 6.